Browsing: Goldman
Goldman Sachs has turned more cautious on Moderna as the biotech struggles against strong competition from other vaccine makers. Analyst…
peterschreiber.mediaGoldman Sachs has initiated coverage of Vera Therapeutics (NASDAQ:VERA) with a buy rating, citing the potential of its drug candidate…
Investors should snap up Vera Therapeutics after a recent retreat, Goldman Sachs suggested. Analyst Paul Choi initiated coverage of the…
Goldman Sachs anticipates a 25bps rate cut from the Bank of Canada at this week’s January meeting, paired with cautious…
Even after a 20% surge on Friday, Goldman Sachs thinks Twilio shares have further room to run. The firm raised…
Jan. 26, 2025 12:23 PM ETS&P 500 Index (SP500)IDXX, AGCO, GRPN, PAYO, CTVA, BILL, DOCN, ACVA, EVCM, WEAVBy: Rob Williams,…
It is not too late to start thinking about moving out of short-term cash instruments and into longer-duration bonds, according…
Goldman Sachs CEO David Solomon has shared his thoughts on the role that Bitcoin plays in the global financial system.…
Guideware Software is at the forefront of the cloud modernization movement, and investors should scoop shares in the company, according…
I’ll review how options traders positioning themselves in the biggest movers post-earnings and identify some stocks where heavy call buying…